| Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non … H Saji, M Okada, M Tsuboi, R Nakajima, K Suzuki, K Aokage, T Aoki, ... The Lancet 399 (10335), 1607-1617, 2022 | 841 | 2022 |
| The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies S Kumagai, Y Togashi, T Kamada, E Sugiyama, H Nishinakamura, ... Nature immunology 21 (11), 1346-1358, 2020 | 578 | 2020 |
| Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial K Suzuki, H Saji, K Aokage, S Watanabe, M Okada, J Mizusawa, ... The Journal of thoracic and cardiovascular surgery 158 (3), 895-907, 2019 | 473 | 2019 |
| Predominant infiltration of macrophages and CD8+ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer O Kawai, G Ishii, K Kubota, Y Murata, Y Naito, T Mizuno, K Aokage, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 463 | 2008 |
| Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments S Kumagai, S Koyama, K Itahashi, T Tanegashima, Y Lin, Y Togashi, ... Cancer Cell 40 (2), 201-218. e9, 2022 | 373 | 2022 |
| A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer K Suzuki, S Watanabe, M Wakabayashi, H Saji, K Aokage, Y Moriya, ... The Journal of thoracic and cardiovascular surgery 163 (1), 289-301. e2, 2022 | 241 | 2022 |
| Genomic profiling of large-cell neuroendocrine carcinoma of the lung T Miyoshi, S Umemura, Y Matsumura, S Mimaki, S Tada, H Makinoshima, ... Clinical Cancer Research 23 (3), 757-765, 2017 | 179 | 2017 |
| Influence of ground glass opacity and the corresponding pathological findings on survival in patients with clinical stage I non–small cell lung cancer K Aokage, T Miyoshi, G Ishii, M Kusumoto, S Nomura, S Katsumata, ... Journal of Thoracic Oncology 13 (4), 533-542, 2018 | 127 | 2018 |
| Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness Y Yamaguchi, G Ishii, M Kojima, K Yoh, H Otsuka, Y Otaki, K Aokage, ... Journal of thoracic oncology 5 (9), 1361-1368, 2010 | 120 | 2010 |
| Prognostic impact of a ground-glass opacity component in clinical stage IA non–small cell lung cancer A Hattori, K Suzuki, K Takamochi, M Wakabayashi, K Aokage, H Saji, ... The Journal of Thoracic and Cardiovascular Surgery 161 (4), 1469-1480, 2021 | 113 | 2021 |
| Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal? A Kawase, J Yoshida, G Ishii, M Nakao, K Aokage, T Hishida, ... Japanese journal of clinical oncology 42 (3), 189-195, 2011 | 113 | 2011 |
| Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma T Kinoshita, G Ishii, N Hiraoka, S Hirayama, C Yamauchi, K Aokage, ... Cancer science 104 (4), 409-415, 2013 | 111 | 2013 |
| Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review K Aokage, J Yoshida, T Hishida, M Tsuboi, H Saji, M Okada, K Suzuki, ... Japanese journal of clinical oncology, 1-5, 2016 | 107 | 2016 |
| A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211) K Aokage, H Saji, K Suzuki, T Mizutani, H Katayama, T Shibata, ... General thoracic and cardiovascular surgery 65, 267-272, 2017 | 106 | 2017 |
| Molecular oncology of lung cancer S Toyooka, T Mitsudomi, J Soh, K Aokage, M Yamane, T Oto, K Kiura, ... General thoracic and cardiovascular surgery 59, 527-537, 2011 | 106 | 2011 |
| Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules M Nakao, J Yoshida, K Goto, G Ishii, A Kawase, K Aokage, T Hishida, ... Journal of Thoracic Oncology 7 (10), 1563-1566, 2012 | 104 | 2012 |
| Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer T Takuwa, J Yoshida, S Ono, T Hishida, M Nishimura, K Aokage, K Nagai The Journal of thoracic and cardiovascular surgery 146 (3), 571-574, 2013 | 96 | 2013 |
| Late recurrence of non-small cell lung cancer more than 5 years after complete resection: incidence and clinical implications in patient follow-up R Maeda, J Yoshida, T Hishida, K Aokage, M Nishimura, Y Nishiwaki, ... Chest 138 (1), 145-150, 2010 | 90 | 2010 |
| Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory … K Aokage, K Suzuki, H Saji, M Wakabayashi, T Kataoka, Y Sekino, ... The Lancet Respiratory Medicine 11 (6), 540-549, 2023 | 87 | 2023 |
| Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid? K Aokage, J Yoshida, G Ishii, T Hishida, M Nishimura, K Nagai Lung Cancer 70 (2), 163-167, 2010 | 80 | 2010 |
Yasuhiro TsutaniKindai University Faculty of Medicine在 med.kindai.ac.jp 的电子邮件经过验证
Yasuhiro TsutaniKindai University Faculty of Medicine在 med.kindai.ac.jp 的电子邮件经过验证